Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b4a80ac02f1ecd0e698ec665e9b36b6 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C65-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C55-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C55-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-29 |
filingDate |
2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4a5a0353ecdaf2d6d4e581ec21fbd8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7023cb8a5ca8c8e927292b0b0490234d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f41d0cc320e88bfc51bd495c0bfa71ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef2f35dde9247b633277856b8a39acdd |
publicationDate |
2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2516704-T3 |
titleOfInvention |
Acid tolterodine salt with effective stability for a transdermal drug delivery system |
abstract |
Tolterodine Hippurate represented by the following formula 3. ** Formula ** |
priorityDate |
2008-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |